Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Pharvaris N.V. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 25 | 22 | −3 |
| Shares | 21.6M | 21.6M | +15.4K (+0.1%) |
| Value | $380.3M | $321.1M | −$59.2M (−15.6%) |
New holders (1)
Institutions that held Pharvaris N.V. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Suvretta Capital Management, LLC | 827,540 | $11.9M | 0.23% |
Sold out (4)
Institutions that held Pharvaris N.V. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| VR Adviser, LLC | 552,882 | $9.80M |
| Compagnie Lombard Odier SCmA | 16,670 | $287.0K |
| Ensign Peak Advisors, Inc | 5,000 | $86.0K |
| Tower Research Capital LLC (TRC) | 211 | $4.00K |